Host	O
-	O
derived	O
angiopoietin	O
-	O
2	O
affects	O
early	O
stages	O
of	O
tumor	B-Cancer
development	O
and	O
vessel	B-Multi-tissue_structure
maturation	O
but	O
is	O
dispensable	O
for	O
later	O
stages	O
of	O
tumor	B-Cancer
growth	O
.	O

The	O
angiopoietin	O
/	O
Tie2	O
system	O
has	O
been	O
identified	O
as	O
the	O
second	O
vascular	B-Multi-tissue_structure
-	O
specific	O
receptor	O
tyrosine	O
kinase	O
system	O
controlling	O
vessel	B-Multi-tissue_structure
assembly	O
,	O
maturation	O
,	O
and	O
quiescence	O
.	O

Angiopoietin	O
-	O
2	O
(	O
Ang	O
-	O
2	O
)	O
is	O
prominently	O
up	O
-	O
regulated	O
in	O
the	O
host	O
-	O
derived	O
vasculature	B-Multi-tissue_structure
of	O
most	O
tumors	B-Cancer
,	O
making	O
it	O
an	O
attractive	O
candidate	O
for	O
antiangiogenic	O
intervention	O
.	O

Yet	O
,	O
the	O
net	O
outcome	O
of	O
Ang	O
-	O
2	O
functions	O
on	O
tumor	B-Cancer
angiogenesis	O
is	O
believed	O
to	O
be	O
contextual	O
depending	O
on	O
the	O
local	O
cytokine	O
milieu	O
.	O

Correspondingly	O
,	O
Ang	O
-	O
2	O
manipulatory	O
therapies	O
have	O
been	O
shown	O
to	O
exert	O
protumorigenic	O
as	O
well	O
as	O
antitumorigenic	O
effects	O
.	O

To	O
clarify	O
the	O
role	O
of	O
Ang	O
-	O
2	O
for	O
angiogenesis	O
and	O
tumor	B-Cancer
growth	O
in	O
a	O
definite	O
genetic	O
experimental	O
setting	O
,	O
the	O
present	O
study	O
was	O
aimed	O
at	O
comparatively	O
studying	O
the	O
growth	O
of	O
different	O
tumors	B-Cancer
in	O
wild	O
-	O
type	O
and	O
Ang	O
-	O
2	O
-	O
deficient	O
mice	O
.	O

Lewis	B-Cancer
lung	I-Cancer
carcinomas	I-Cancer
,	O
MT	B-Cancer
-	I-Cancer
ret	I-Cancer
melanomas	I-Cancer
,	O
and	O
B16F10	B-Cancer
melanomas	I-Cancer
all	O
grew	O
slower	O
in	O
Ang	O
-	O
2	O
-	O
deficient	O
mice	O
.	O

Yet	O
,	O
tumor	B-Cancer
growth	O
in	O
wild	O
-	O
type	O
and	O
Ang	O
-	O
2	O
-	O
deficient	O
mice	O
dissociated	O
during	O
early	O
stages	O
of	O
tumor	B-Cancer
development	O
,	O
whereas	O
tumor	B-Cancer
growth	O
rates	O
during	O
later	O
stages	O
of	O
primary	B-Cancer
tumor	I-Cancer
progression	O
were	O
similar	O
.	O

Analysis	O
of	O
the	O
intratumoral	B-Multi-tissue_structure
vascular	I-Multi-tissue_structure
architecture	I-Multi-tissue_structure
revealed	O
no	O
major	O
differences	O
in	O
microvessel	B-Tissue
density	O
and	O
perfusion	O
characteristics	O
.	O

However	O
,	O
diameters	O
of	O
intratumoral	B-Tissue
microvessels	I-Tissue
were	O
smaller	O
in	O
tumors	B-Cancer
grown	O
in	O
Ang	O
-	O
2	O
-	O
deficient	O
mice	O
,	O
and	O
the	O
vasculature	B-Multi-tissue_structure
had	O
an	O
altered	O
pattern	O
of	O
pericyte	B-Cell
recruitment	O
and	O
maturation	O
.	O

Ang	B-Tissue
-	I-Tissue
2	I-Tissue
-	I-Tissue
deficient	I-Tissue
tumor	I-Tissue
vessels	I-Tissue
had	O
higher	O
pericyte	B-Cell
coverage	O
indices	O
.	O

Recruited	O
pericytes	B-Cell
were	O
desmin	O
and	O
NG2	O
positive	O
and	O
predominately	O
alpha	O
-	O
smooth	O
muscle	O
actin	O
negative	O
,	O
indicative	O
of	O
a	O
more	O
mature	O
pericyte	B-Cell
phenotype	O
.	O

Collectively	O
,	O
the	O
experiments	O
define	O
the	O
role	O
of	O
Ang	O
-	O
2	O
during	O
tumor	B-Cancer
angiogenesis	O
and	O
establish	O
a	O
better	O
rationale	O
for	O
combination	O
therapies	O
involving	O
Ang	O
-	O
2	O
manipulatory	O
therapies	O
.	O

